Home » Neurodegeneration » Page 2
Tag:

Neurodegeneration

Health

Stem Cells Reverse Stroke Damage: New Hope for Brain Disorders

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Stem Cell Therapy Shows⁤ Promise in Restoring Brain Function After Stroke

new research⁢ from the University of Zurich ⁣(UZH) demonstrates that ‍transplanting​ neural stem cells into the brains of mice experiencing⁢ stroke can lead to meaningful functional recovery ​and evidence of brain regeneration.The findings, published in‌ Nature Communications, suggest a potential pathway towards effective stroke treatment in humans.

Researchers induced stroke in⁢ mice, mimicking the condition as​ it manifests in humans, and genetically ​modified ​the animals to accept human stem cells. One week post-stroke,they⁣ transplanted neural stem cells​ derived from induced pluripotent stem cells (iPSCs) – created from normal human somatic cells – into the damaged brain region.

Over a five-week observation period, the team utilized imaging and biochemical analyses to ⁤track the stem cells’ progress. ‌They discovered the cells survived and largely ⁢differentiated into functional neurons, successfully integrating and communicating with⁤ existing brain cells. Importantly, the ⁤transplantation also triggered regenerative processes, including the formation of new blood vessels, a reduction ‍in inflammation, and improved integrity of the blood-brain barrier.

The therapy demonstrably‌ reversed motor impairments caused​ by the stroke, as confirmed by AI-assisted analysis ​of the ⁣mice’s gait. ⁣ A key finding was that delaying stem cell transplantation by one week after the stroke actually yielded better results, potentially simplifying therapy preparation in a clinical setting.

The research ‌team proactively addressed potential hurdles for human request.​ The stem cells were manufactured without ‌animal-derived reagents,⁢ utilizing a protocol ​developed in collaboration‍ with the Center for iPS Cell Research and Application (CiRA) at Kyoto ⁤University.

While acknowledging the encouraging results, lead researcher tackenberg emphasizes the need for further development.Current efforts focus on creating a “safety switch” to prevent uncontrolled stem cell growth and exploring endovascular injection – a⁢ less ⁣invasive delivery method​ than direct brain grafting. Clinical ⁣trials utilizing iPSC-derived cells are ​already ​underway​ in Japan for‌ Parkinson’s disease,and Tackenberg believes stroke could be a future target for similar clinical inquiry.

Source: ‍University of Zurich (UZH). “Stroke: Stem cell therapy restores brain function.” news.uzh.ch, https://www.news.uzh.ch/en/articles/media/2025/stroke.html. Accessed May 16, 2024.

Journal Reference: Weber, R. ‌Z.,et al. (2025). Neural ⁤xenografts contribute​ to long-term‍ recovery in stroke⁢ via molecular graft-host crosstalk. ⁣ nature Communications. doi.org/10.1038/s41467-025-63725-3.

0 comments
0 FacebookTwitterPinterestEmail
Health

Boosting PI31: A New Strategy for Neurodegenerative Diseases

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Restoring the Cellular Cleanup Crew: A Potential New Approach to Neurodegenerative Disease

For years, the prevailing theory in neurodegenerative diseases like alzheimer’s, ALS, and Parkinson’s focused on the buildup of protein aggregates as the primary cause of neuronal damage. However, research led by the Steller lab suggests a different starting point: a breakdown in the delivery of the cell’s protein-degrading machinery, known as proteasomes, to synapses. These vital components are responsible for clearing out damaged proteins, maintaining healthy neuronal communication. When proteasome transport falters, waste accumulates, and synaptic function deteriorates.This viewpoint shifts the focus from simply clearing existing damage to proactively maintaining the cellular cleanup system.

A key protein identified in this transport process is PI31. This protein acts as an adaptor, loading proteasomes onto cellular motors for their journey to synapses and ensuring their proper assembly upon arrival. Studies have shown that without sufficient PI31, proteasome transport is disrupted, leading to protein buildup and the eventual formation of aggregates. Loss-of-function mutations in PI31, and in genes coding for related proteins, have been linked to several neurodegenerative diseases. Notably, genetic variations in the PI31 gene have been observed in patients diagnosed with Alzheimer’s, ALS, and Parkinson’s disease.

Driven by these findings, Steller’s team investigated whether boosting PI31 levels could prevent neurodegeneration, utilizing a model based on the rare genetic disorder caused by mutations in the FBXO7 gene. This disorder results in an early-onset, Parkinson’s-like syndrome in humans, and importantly, FBXO7 levels are directly correlated with PI31 levels – loss of FBXO7 leads to a decrease in PI31.

Initial experiments using fruit fly models mimicking FBXO7 deficiency demonstrated severe motor defects and impaired proteasome transport.Though, introducing extra copies of the PI31 gene reversed these symptoms, restoring proper proteasome movement. These promising results were then replicated in FBXO7-deficient mice. even modest increases in PI31 levels substantially suppressed neuronal degeneration, preserved motor function, and improved overall health. Remarkably,in certain specific cases,the lifespan of these mice was extended nearly fourfold. Furthermore, increased PI31 levels facilitated the clearance of abnormal tau proteins, a characteristic feature of Alzheimer’s disease.

These results strongly suggest that increasing PI31 expression can effectively maintain proteasome transport and prevent the progression of neurodegenerative hallmarks in both flies and mice. Current research is focused on determining whether PI31 can preserve cognitive function in aging mice, paving the way for potential preclinical growth of therapies for humans.

Recent collaborative research from the Steller lab has identified rare human mutations in the PI31 gene associated with a range of neurodegenerative conditions.This discovery suggests that PI31-based therapies could initially target these rare disorders caused by FBXO7 or PI31 deficiency. Steller anticipates that insights gained from treating these conditions could ultimately inform broader strategies for slowing age-related cognitive decline and addressing more prevalent neurodegenerative diseases like Alzheimer’s.

0 comments
0 FacebookTwitterPinterestEmail
Health

Vitamin K Analogs Enhance Neuronal Differentiation for Neurodegenerative Diseases

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Novel Vitamin K Analogs Show Promise in Neurodegenerative Disease treatment

Researchers have developed novel vitamin K analogs with‍ significantly enhanced neuroprotective and neuronal differentiation-inducing properties, offering a potential new avenue for treating neurodegenerative diseases like Alzheimer’s.The study, conducted at the Shibaura Institute of⁤ Technology and published in ACS Chemical Neuroscience, ​details the creation and testing of ​hybrid compounds combining⁣ structural elements of vitamin K⁢ and retinoic acid.

Vitamin K and retinoic acid exert their biological effects by regulating transcriptional activity through the steroid and xenobiotic receptor (SXR) and retinoic acid receptor (RAR), respectively.The researchers synthesized hybrid‌ homologs of these compounds and found that ‌they retained the biological activity‌ of both parent molecules when tested on mouse neural progenitor cells. Specifically, ‍a compound incorporating both the⁣ conjugated ‌structure of retinoic ⁢acid and a methyl ester side chain demonstrated a three-fold increase in neuronal differentiation activity compared to​ controls and outperformed natural vitamin K compounds – designated as a “Novel vitamin K analog” (Novel VK).Neuronal differentiation was quantified by measuring the expression of microtubule-associated ⁣protein 2 (Map2), ⁤a ‍key marker of neuronal growth.

To⁣ understand ‌ how ⁢ vitamin K exerts its neuroprotective​ effects, the team compared ​gene expression profiles of neural stem cells treated with MK-4, a known differentiation-inducing compound, to those treated ⁣with a differentiation-suppressing compound. This analysis revealed that metabotropic glutamate receptors (mGluRs) play a crucial role in mediating vitamin K-induced neuronal differentiation, operating through downstream epigenetic and transcriptional regulation. The effect was specifically linked to mGluR1, a ⁢receptor previously associated with synaptic transmission and whose deficiency in‍ mice leads ⁢to motor and synaptic dysfunction – hallmarks of neurodegenerative diseases.

Further inquiry using structural simulations and molecular docking studies confirmed a direct interaction between Novel VK and mGluR1, revealing a stronger binding affinity than‍ observed with natural vitamin K. Crucially, the researchers demonstrated that Novel VK is readily converted to the bioactive MK-4 both in vitro and in vivo. Cellular uptake studies showed a ⁣concentration-dependent increase in intracellular MK-4 levels, and mice treated with Novel VK ‍exhibited a more stable pharmacokinetic profile, efficient blood-brain barrier ‌penetration, and higher brain concentrations‌ of MK-4 compared ⁢to controls.

these findings illuminate the mechanism behind vitamin K’s neuroprotective effects and suggest that structurally modified analogs like Novel VK can significantly enhance these benefits.As Dr. Hirota, the lead researcher, states, “Our research offers a potentially groundbreaking ​approach ​to ⁢treating neurodegenerative diseases. ⁣A vitamin‌ K-derived drug that slows the progression of Alzheimer’s disease or improves its ⁤symptoms coudl not⁤ only ⁢improve the quality⁣ of life for patients and their families but also significantly reduce the growing societal burden of healthcare expenditures⁣ and long-term caregiving.” The study represents a promising step ​towards the ‌growth of novel therapeutic agents for neurological diseases,offering hope for improved treatments and a better future for patients and their families.

Source: Shibaura Institute of Technology. Hirota, Y., et⁣ al. (2025).​ A New Class of Vitamin K Analogues Containing the Side Chain of Retinoic⁤ Acid Have Enhanced Activity for Inducing‍ Neuronal Differentiation. ACS Chemical Neuroscience. doi.org/10.1021/acschemneuro.5c00111.

0 comments
0 FacebookTwitterPinterestEmail
Health

Brain Reorganization: Compensating for Neuron Loss in Auditory Cortex

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Brain’s Remarkable Resilience: Neural Networks Adapt to Neuron​ Loss

Table of Contents

Mainz, Germany – In a significant breakthrough, ‍researchers at the University Medical Center Mainz have demonstrated the brain’s surprising capacity to maintain function even as nerve cells are lost-a phenomenon ‍particularly relevant to age-related cognitive decline and neurodegenerative diseases. The study, published recently, offers actionable insights into the ⁢brain’s‍ compensatory mechanisms and potential therapeutic strategies.

The Auditory Cortex and Neural Mapping

The brain organizes sensory information, such as sound, into “depiction⁣ maps” within areas⁣ like the auditory cortex. These maps rely on specific patterns of neural activity. Despite the natural loss of neurons with age or disease, these maps‌ frequently enough​ remain remarkably ‌stable. Scientists have long sought to understand how the brain preserves these critical functions‌ in the face⁣ of neuronal degeneration.

Experimental Study Reveals Homeostasis Mechanisms

Researchers, lead by ‌prof. Dr. Simon Rumpel, conducted a targeted study using a mouse model to investigate the brain’s response to‌ neuron loss. They employed laser micro-ablation to selectively remove neurons within the auditory cortex, then meticulously analyzed the resulting effects on the auditory representation map. This approach‌ allowed for a controlled examination⁣ of the brain’s ​homeostatic responses.

Sound-Inactive Neurons Step In

The team discovered​ that the initial loss of neurons caused a⁢ temporary disruption of the auditory map. However,within days,the map stabilized as previously inactive ​neurons began ⁤processing sound stimuli,effectively ‍taking ‍over the function of the lost cells. This demonstrates a remarkable level of neural plasticity and adaptability.

Pro Tip: Understanding neural plasticity is key to unlocking potential therapies for brain injuries and neurodegenerative conditions.

Inhibitory Neurons Play a Critical Role

Interestingly, the⁤ targeted removal‍ of inhibitory neurons-cells that regulate neural activity-resulted in a prolonged destabilization of the auditory map. This finding highlights the crucial role of inhibitory neurons in maintaining network stability and preventing runaway excitation. ‍ This aligns with established principles of neural circuit function, ‌where a balance between excitation and inhibition is‌ essential for ⁢proper processing [[1]].

A Potential Pathway⁤ for therapeutic Intervention

“With ⁢our studies, we have uncovered that neural networks in the brain have a remarkable potential for reorganization,”‌ stated Prof. Dr. Rumpel in⁣ a press release.”We‍ assume that this newly discovered neuronal mechanism could also⁣ play an significant role in the loss of nerve cells ⁢in natural aging processes and in neurodegenerative diseases.” The research suggests that future efforts could‌ focus on enhancing these natural‌ reorganization processes.

Translating findings to Human Conditions

The study’s findings raise the important question of whether similar mechanisms operate in the human brain. Further research is needed ‍to ⁢determine the extent to ​which these processes can be harnessed therapeutically,particularly in the context of⁣ Alzheimer’s disease and Parkinson’s disease. Could targeted interventions ⁤stimulate the recruitment of inactive neurons and bolster network stability in patients?

Did You know? ⁣parkinson’s disease affects over ⁤10 million people worldwide, and Alzheimer’s disease is the most common cause of dementia, impacting tens of millions more.

Key Study Findings

Finding Details
Neural Map Stability Auditory representation maps remain stable despite neuron loss.
Inactive Neuron Recruitment Previously inactive neurons take over function after neuron⁢ ablation.
Inhibitory Neuron Importance Removal‌ of inhibitory neurons leads to long-term ⁤map destabilization.
Potential Therapeutic Target Enhancing neural reorganization could benefit neurodegenerative diseases.

the research underscores the brain’s inherent resilience and it’s ability to adapt to challenges. This understanding is crucial for developing‌ effective strategies to mitigate the effects of age-related cognitive decline and neurodegenerative diseases.

The Future of Neuroplasticity Research

The field of neuroplasticity-the brain’s ability to‌ reorganize itself‍ by forming new neural connections throughout⁢ life-is rapidly evolving. recent advances in neuroimaging techniques, ⁢such as functional magnetic resonance imaging (fMRI), are providing unprecedented insights into the dynamic changes occurring within the brain. researchers are also exploring the potential of non-invasive brain stimulation techniques, like transcranial magnetic stimulation (TMS), to enhance neuroplasticity and promote recovery after brain ⁣injury or stroke. the ⁣convergence of these technologies promises ⁤to unlock new therapeutic avenues for a wide range of neurological and psychiatric disorders.

Frequently Asked Questions

  • What​ is neural plasticity? Neural plasticity refers to the brain’s ability​ to change and adapt in ⁤response to experience, forming new connections and reorganizing existing ones.
  • How does the brain compensate for‍ neuron loss? The brain can compensate for neuron loss by recruiting previously inactive neurons to take over the functions‌ of the lost cells.
  • What role do inhibitory neurons play in brain function? Inhibitory neurons are crucial for maintaining network stability and preventing overexcitation in the brain.
  • Could this research lead to new treatments⁤ for Alzheimer’s disease? While further ⁣research is needed,⁤ this study suggests that enhancing the brain’s natural ⁢reorganization processes could⁣ be a potential therapeutic strategy for Alzheimer’s and other neurodegenerative diseases.
  • Is this brain reorganization process unique‍ to the auditory cortex? While this study focused⁤ on the auditory‌ cortex, similar ‍mechanisms of‌ neural plasticity are likely to occur in other brain regions as well.

This research offers a beacon of hope in the fight against neurodegenerative diseases. ‌We encourage you to share this ⁤article with ​your network and join the conversation in the comments below. Don’t forget‌ to subscribe to World Today ⁢News for the latest breakthroughs in science and ‍health!

0 comments
0 FacebookTwitterPinterestEmail
Health

Multiple Sclerosis: New Insights into Inflammation and Neurodegeneration

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Unlocking‍ New MS Therapies: Study Reveals ‌Key Link Between Inflammation ⁣and Neuronal Damage

Table of Contents

hamburg, Germany​ – A new study published in ‍the journal Cell offers a‍ strategic ⁣breakthrough in understanding the ‌complex ⁤mechanisms driving⁢ multiple sclerosis (MS). Researchers at the University Hospital ‌Hamburg-Eppendorf have pinpointed a precise connection between neuroinflammation and the degeneration of neurons, perhaps opening⁤ avenues for‌ innovative treatments. This research focuses‍ on the impact of ⁢inflammation on neuronal​ metabolism and identifies specific molecular targets for therapeutic intervention.

The Central Role of Inflammation in‍ Multiple Sclerosis

Multiple sclerosis is a chronic‍ inflammatory‍ disease⁤ of the central nervous system. ⁢the condition arises ⁣when the immune system mistakenly attacks myelin, ⁤the protective ‌sheath surrounding⁤ nerve fibers, disrupting ​communication between the brain‌ and the body [[2]].This⁢ immune‌ response triggers a cascade⁢ of inflammatory reactions and neurodegenerative processes,ultimately leading to neuronal ⁢damage.

A long-standing‌ challenge in MS research has ​been fully elucidating the ⁤relationship between chronic inflammation and the resulting neuronal harm.‍ This ⁢new study provides critical insights into this connection.

How Inflammation Drives ​Neuronal Cell Death

The research team,⁣ led by Woo ‌et al., demonstrated that neuroinflammation and ‍a disrupted neuronal metabolism contribute‍ to neuronal decline. Specifically, the study highlights the role of interferon-gamma (IFN-γ), a signaling ​molecule that⁢ modulates ‌the immune-proteasome-a complex responsible for protein homeostasis within⁢ nerve cells. Inhibition⁤ of protein reduction,‌ triggered by IFN-γ,‌ leads to ⁢oxidative stress ‌and, ultimately, ‍cell death.

Did You Know? Multiple sclerosis affects⁤ over 2.8 million people worldwide, with symptoms ‌varying widely‍ in severity ‌and presentation.

PFKFB3 Accumulation: A Key Pathological process

Using‍ advanced molecular, biochemical, ⁣and genetic techniques, the researchers identified a central‌ pathway driving this process:

  • IFN-γ induces Proteasom 20S ⁣Beta ‌8​ (PSMB8) expression in neurons.
  • The ‍incorporation of PSMB8 into⁣ the‌ immune proteasome impairs protein degradation within neurons.
  • This ⁤impairment leads to an accumulation of phosphofructo-2-kinase/fructose-2,6-biphosphatase 3⁢ (PFKFB3) within neurons.
  • Elevated PFKFB3 levels promote a metabolic shift toward increased glycolysis, reduced antioxidant capacity, and heightened susceptibility to ferroptosis-an iron-dependent form of programmed cell death.

Importantly, the study revealed‌ that ​PSMB8 expression is⁤ specifically pathological in neurons. Genetic deletion or‌ pharmacological ‌inhibition of PSMB8 significantly reduced neuronal degeneration.

Potential for Novel⁣ MS Therapies

These findings identify PSMB8 and ⁤PFKFB3 as promising therapeutic targets, operating independently of conventional immunomodulatory approaches.Given the limited efficacy of existing therapies ​in the chronic-progressive ‌phase of MS, modulating neuronal proteasome‌ activity​ could represent a groundbreaking approach. ⁣The ⁢researchers suggest further examination into the role‌ of these mechanisms in other neurodegenerative diseases, such ⁢as Alzheimer’s and Parkinson’s⁤ disease.

Pro Tip: Maintaining a healthy lifestyle, including regular exercise ​and​ a balanced diet, can ‌play​ a supportive⁣ role in‌ managing MS symptoms.

Study Details and Key⁣ Findings

Key Finding mechanism Implication
IFN-γ induces⁣ PSMB8 Modulates ⁤immune-proteasome activity Disrupts ​protein homeostasis
PFKFB3 Accumulation Metabolic⁤ shift towards‌ glycolysis Increases⁤ oxidative stress and ferroptosis
PSMB8 Inhibition reduces neuronal degeneration Potential therapeutic target

Future Directions and Neuroprotective Strategies

The study ‌by Woo et al. provides compelling evidence that inflammatory changes in neuronal proteasome composition-notably through PSMB8-are⁣ central ‍drivers of metabolic dysfunction and neurodegeneration in MS. The PFKFB3-dependent shift towards glycolysis ⁤exacerbates oxidative stress and ferroptosis. Targeting this ‌signaling pathway offers promising prospects for neuroprotective therapies in⁢ MS and​ potentially other‌ neurodegenerative conditions. What further research is ‍needed to‍ translate these findings into clinical applications? How ‍might these discoveries ‍impact ‌the long-term management of ‍MS for⁣ patients?

Understanding ⁤the Landscape​ of Multiple Sclerosis

Multiple sclerosis is an autoimmune ⁣disease affecting ​the brain ​and spinal ⁢cord.⁤ Symptoms can​ range from mild, such as numbness and fatigue, to severe, including ⁢paralysis. The disease course is unpredictable, with periods of remission and relapse. Current treatments focus on managing symptoms and slowing disease ⁢progression, but a cure remains elusive. Ongoing research is crucial⁢ to developing more effective therapies and ultimately preventing ‌the disease.

Frequently Asked Questions about Multiple Sclerosis

  • What is multiple sclerosis? MS is a chronic,often ​disabling‍ disease that affects the central nervous system.
  • What ⁤are the common symptoms of MS? Common symptoms include fatigue,‍ difficulty walking, ⁣numbness, and‌ vision problems.
  • Is ther ⁣a cure for multiple sclerosis? Currently, there ⁢is ‍no​ cure ‌for MS, but treatments ⁣can ‌definitely help manage symptoms and slow disease progression.
  • What causes multiple sclerosis? The exact cause of MS is unknown, but it⁢ is ⁣believed to be⁤ a combination of genetic and environmental factors.
  • How is multiple sclerosis diagnosed? Diagnosis typically⁤ involves a ⁤neurological exam, MRI scans, and‍ sometimes a spinal ⁢tap.

Disclaimer: This article provides⁤ general data and⁢ should not be considered medical advice. Please consult with a⁣ qualified healthcare professional for any health concerns or ⁣before​ making any decisions related to⁣ your health or treatment.

we hope this ‍article‌ has provided valuable insights into ⁣the latest research⁣ on multiple sclerosis.Share this information with your‍ network to raise awareness and support ongoing research efforts. Subscribe to our‍ newsletter for more breaking ​news and ⁤in-depth analysis on health and ‌science.

0 comments
0 FacebookTwitterPinterestEmail
Health

Superpowers of Hibernating Animals Could Lie Hidden in Human DNA

by Dr. Michael Lee – Health Editor
written by Dr. Michael Lee – Health Editor

Hibernation Secrets Could Reverse Disease

Unlocking dormant genetic abilities may hold keys to treating neurodegeneration and diabetes.

Researchers are exploring the remarkable resilience of hibernating animals, like ground squirrels and bats, hoping to uncover genetic mechanisms that could combat human diseases such as diabetes and neurodegenerative conditions.

Gene Regulation Sparks New Hope

A critical gene cluster, known as the FTO locus, plays a significant role in hibernation, allowing animals to efficiently manage weight gain and fat utilization. Intriguingly, humans possess these same genes, which are strongly linked to obesity. However, hibernators appear to utilize the FTO locus and its surrounding DNA in novel ways.

University of Utah scientists have pinpointed specific DNA regions in hibernators that regulate the activity of nearby genes, effectively fine-tuning their metabolic functions. These regulatory regions, distinct from genes themselves, act like an orchestra conductor, influencing the expression of numerous genes.

“This means that mutating a single hibernator-specific region has wide-ranging effects extending far beyond the FTO locus. When you knock out one of these elements — this one tiny, seemingly insignificant DNA region — the activity of hundreds of genes changes. It’s pretty amazing.”

—Dr. Susan Steinwand, Lead Researcher

When these unique regulatory regions were altered in mice, the animals exhibited significant shifts in weight, metabolism, and their ability to recover body temperature after simulated hibernation. This suggests that subtle genetic modifications can unlock profound metabolic flexibility.

A Blueprint for Human Health

The groundbreaking research, published in two separate studies in the journal *Science*, suggests that humans may already possess the genetic blueprint for hibernation-like adaptations. The challenge lies in identifying and controlling the specific “switches” that govern these dormant abilities.

Studying the evolution of hibernators like hedgehogs, bats, ground squirrels, and lemurs could reveal the secrets of their remarkable resilience. Image credit: Chrissy Richards.

Scientists identified these crucial genetic regions by looking for DNA sequences that have evolved rapidly in hibernating mammals compared to other species. They also analyzed genes that act as central coordinators of metabolic changes, particularly those triggered by fasting in mice, which mimic some aspects of hibernation.

By understanding how hibernators manage to avoid muscle atrophy, stay healthy through dramatic weight fluctuations, and achieve remarkable longevity, researchers believe they can develop strategies to confer similar resilience to humans. This could involve targeting specific genetic control mechanisms to combat age-related diseases and metabolic disorders.

“If we could regulate our genes a bit more like hibernators, maybe we could overcome type 2 diabetes the same way that a hibernator returns from hibernation back to a normal metabolic state,” stated Dr. Elliott Ferris, a lead author on one of the studies.

The potential implications are vast, offering a novel pathway to enhance human health by learning from the naturally preserved genetic code that grants hibernators their extraordinary metabolic powers.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts
@2025 - All Right Reserved.

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: contact@world-today-news.com